MDC 0.00% $6.60 medlab clinical limited

Ann: Reminder of Investor Webinar - NanaBis Phase III Trial, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,445 Posts.
    lightbulb Created with Sketch. 337
    The market must see better medical cannabis investment opportunities elsewhere at present compared to Medlab's cancer pain opioid alternative medicine and Phase3 is not good enough for the market.

    LGP/MXC/CPH/BOT all seem to have a better market offering than Chronic pain phase3 trial of Medlab.
 
watchlist Created with Sketch. Add MDC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.